Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer

Journal of Gene Medicine

Volumn 10, Issue 8, 2008, Pages 918-929

  Jiang, Zhenggang ^a   Xu, Wei ^a   Li, Kang ^a   Yue, Yan ^a   Xu, Lin ^a   Ye, Fei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Institute of Immunology   (China)

Author keywords

Coxsackievirus B3; Hydrodynamics based gene transfection; Iinterleukin 4; Myocarditis; Th polarization

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 4; PLASMID DNA; RECOMBINANT INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DISEASE SEVERITY; DRUG EFFICACY; GENE INDUCTION; HEART; HYDRODYNAMICS BASED TRANSFECTION; IN VIVO GENE TRANSFER; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REMISSION; SURVIVAL RATE; TH2 CELL; TISSUE LEVEL; VIRUS MYOCARDITIS; WEIGHT REDUCTION;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENE TRANSFER TECHNIQUES; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; RECURRENCE; TH2 CELLS;

COXSACKIEVIRUS; MUS;

EID: 49349101920     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1215     Document Type: Article

References (43)

1. Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 2007; 41: 118-122.
2. Fairweather D, Kaya Z, Shellam GR, et al. From infection to autoimmunity. J Autoimmun 2001; 16: 175-186.
3. Deonarain R, Cerullo D, Fuse K, et al. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004; 110: 3540-3543.
4. Muir P, Kämmerer U, Korn K, et al. Molecular typing of enteroviruses: Current status and future requirements. Clin Microbiol Rev 1998; 11: 202-227.
5. Why HJ, Meany BT, Richardson PJ, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-2589.
6. Klingel K, Kandolf R. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand J Infect Dis Suppl 1993; 88: 79-85.
7. Badorff C, Fichtlscherer B, Rhoads RE, et al. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2 A through S-nitrosylation: a protective mechanism against enteroviral cardiomyopathy. Circulation 2000; 102: 2276-2281.
8. Henke A, Nestler M, Strunze S, et al. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology 2001; 289: 15-22.
9. Fuse K, Chan G, Liu Y, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 2005; 112: 2276-2285.
10. Leipner C, Grun K, Borchers M, et al. The outcome of coxsackievirus B3- (CVB3-) induced myocarditis is influenced by the cellular immune status. Herz 2000; 25: 245-248.
11. + cytolytic lymphocytes. Cell Immunol 1984; 88: 558-567.
12. Woodruff JF, Woodruff JJ. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol 1974; 113: 1726-1734.
13. Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res 1999; 85: 551-558.
14. Huber SA, Pfaeffle B. Differential Thl and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol 1994; 68: 5126-5132.
15. + Thl cells. J Virol 2002; 76: 10785-10790.
16. Huber SA, Polgar J, Schultheiss P, et al. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 1994; 68: 195-206.
17. Lane JR, Neumann DA, Lafond-Walker A, et al. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B1 mice. J Exp Med 1992; 175: 1123-1129.
18. + T cells regulate major histocompatibility complex class II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J Virol 1999; 73: 5630-5636.
19. Murphy E, Shibuya K, Hosken N, et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996; 183: 901-913.
20. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-1266.
21. + T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995; 69: 6720-6728.
22. + T cell effectors that cause myocarditis. J Clin Invest 2003; 111: 671-680.
23. Brzezinski M, Yanay O, Waldron L, et al. G-CSF-lentivirus administration in rats provided sustained elevated neutrophil counts and subsequent EPO-lentivirus administration increased hematocrits. J Gene Med 2007; 9: 571-578.
24. Fu CL, Chuang YH, Chau LY, et al. Effects of adenovirus-expressing IL-10 in alleviating airway inflammation in asthma. J Gene Med 2006; 8: 1393-1399.
25. Hwang SK, Kwon JT, Park SJ, et al. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. Gene Ther 2007; 24: 1721-1730.
26. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
27. Sun WH, Burkholder JK, Sun J, et al. in vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 1995; 92: 2889-2893.
28. Furth PA, Kerr D, Wall R. Gene transfer by jet injection into differentiated tissues of living animals and in organ culture. Mol Biotechnol 1995; 4: 121-127.
29. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
30. Li K, Welikson RE, Vikstrom KL, et al. Direct gene transfer into the mouse heart. J Mol Cell Cardiol 1997; 29: 1499-1504.
31. Choate KA, Khavari PA. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 1997; 8: 1659-1665.
32. Rook GA. Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 2007; 7: 327-337.
33. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007; 117: 1119-1127.
34. Peluso I, Pallone F, Monteleone G. Interleukin-12 and Thl immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006; 12: 5606-5610.
35. + T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J Immunol 2000; 165: 4174-81.
36. Chapman NM, Kim KS, Tracy S, et al. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice. J Virol 2000; 74: 7952-7962.
37. Henke A, Zell R, Ehrlich G, et al. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J Virol 2001; 75: 8187-8194.
38. Nishio R, Matsumori A, Shioi T, et al. Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999; 100: 1102-1108.
39. Henke A, Jarasch N, Martin U, et al. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease. Int J Med Microbiol 2007; 198: 127-134.
40. Jarasch N, Martin U, Kamphausen E, et al. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. Viral Immunol 2005; 18: 355-364.
41. Henke A, Zell R, Martin U, et al. Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3. Virology 2003; 315: 335-344.
42. Kägi D, Seiler P, Pavlovic J, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995; 25: 3256-3262.
43. Huber SA. Autoimmunity in myocarditis: relevance of animal models. Clin Immunol Immunopathol 1997; 83: 93-102.